These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 6155359

  • 1. Angiogenic activity of vitreous and retinal extract.
    Chen CH, Chen SC.
    Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):596-602. PubMed ID: 6155359
    [No Abstract] [Full Text] [Related]

  • 2. Cellular and molecular mechanisms in angiogenesis.
    McAuslan BR, Gole GA.
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):354-8. PubMed ID: 6171067
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of corneal vascularization.
    Eisenstein R.
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):374-6. PubMed ID: 6171071
    [No Abstract] [Full Text] [Related]

  • 4. Chemical mediators of intraocular neovascularization.
    Glaser BM, D'Amore PA, Lutty GA, Fenselau AH, Michels RG, Patz A.
    Trans Ophthalmol Soc U K (1962); 1980 Sep; 100(3):369-73. PubMed ID: 6171070
    [Abstract] [Full Text] [Related]

  • 5. Vitreous: an inhibitor of retinal extract-induced neovascularization.
    Lutty GA, Thompson DC, Gallup JY, Mello RJ, Patz A, Fenselau A.
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):52-6. PubMed ID: 6186631
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a chemoattractant for endothelium induced by angiogenesis effectors.
    Raju KS, Alessandri G, Gullino PM.
    Cancer Res; 1984 Apr; 44(4):1579-84. PubMed ID: 6200213
    [Abstract] [Full Text] [Related]

  • 7. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
    You JJ, Yang CH, Huang JS, Chen MS, Yang CM.
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
    [Abstract] [Full Text] [Related]

  • 8. [Bioassays of the angiogenic activity of tumor fractions on modified chick embryo chorioallantoic membrane. The absence of angiogenic effects].
    Aliev MK, Petukhov VB, Pozdniakov VS, Flotskaia NV, Ivanov VN.
    Zh Obshch Biol; 1982 Nov; 43(2):229-42. PubMed ID: 7080671
    [No Abstract] [Full Text] [Related]

  • 9. Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.
    Taylor CM, Kissun RD, Schor AM, McLeod D, Garner A, Weiss JB.
    Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2174-8. PubMed ID: 2477343
    [Abstract] [Full Text] [Related]

  • 10. [Angiogenesis factor in intraocular tumors].
    Barraquer RI, Domenech Mateu JM, Fernández Cotero JN, Muiños Muro SJ, Iglesias Touriño E.
    Rev Esp Oncol; 1982 Oct; 29(3):413-21. PubMed ID: 6084270
    [Abstract] [Full Text] [Related]

  • 11. Mechanism of the induction of angiogenesis by human neoplastic lymphoid tissue: studies employing bovine aortic endothelial cells in vitro.
    Mostafa LK, Jones DB, Wright DH.
    J Pathol; 1980 Nov; 132(3):207-16. PubMed ID: 6159467
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial cell effectors in fetal calf retina, vitreous, and serum.
    Chen SC, Chen CH.
    Invest Ophthalmol Vis Sci; 1982 Sep; 23(3):340-50. PubMed ID: 7107160
    [Abstract] [Full Text] [Related]

  • 13. The inhibition of corneal vascularization with aortic extracts in rabbits.
    Eisenstein R, Goren SB, Shumacher B, Choromokos E.
    Am J Ophthalmol; 1979 Dec; 88(6):1005-12. PubMed ID: 92893
    [Abstract] [Full Text] [Related]

  • 14. Tumor-derived angiogenesis factors from rat Walker 256 carcinoma: an experimental investigation and review.
    Vallee BL, Riordan JF, Lobb RR, Higachi N, Fett JW, Crossley G, Bühler R, Budzik G, Breddam K, Bethune JL.
    Experientia; 1985 Jan 15; 41(1):1-15. PubMed ID: 2578407
    [Abstract] [Full Text] [Related]

  • 15. Purified tumour angiogenesis factor enhances proliferation of capillary, but not aortic, endothelial cells in vitro.
    Keegan A, Hill C, Kumar S, Phillips P, Schor A, Weiss J.
    J Cell Sci; 1982 Jun 15; 55():261-76. PubMed ID: 7107726
    [Abstract] [Full Text] [Related]

  • 16. Stromal vascularization prevents corneal ulceration.
    Conn H, Berman M, Kenyon K, Langer R, Gage J.
    Invest Ophthalmol Vis Sci; 1980 Apr 15; 19(4):362-70. PubMed ID: 6153640
    [Abstract] [Full Text] [Related]

  • 17. [Effect of preparations from the vitreous body having anti-angiogenic properties on the metastatic spread of Lewis lung carcinoma].
    Sopotsinskaia EB, Lisniak IA, Balitskiĭ KP.
    Eksp Onkol; 1987 Apr 15; 9(2):55-7. PubMed ID: 2438110
    [Abstract] [Full Text] [Related]

  • 18. A new approach to the problem of retinal neovascularization.
    Patz A, Brem S, Finkelstein D, Chen CH, Lutty G, Bennett A, Coughlin WR, Gardner J.
    Ophthalmology; 1978 Jun 15; 85(6):626-37. PubMed ID: 580956
    [Abstract] [Full Text] [Related]

  • 19. SIALIC ACIDS IN THE EYE. DISTRIBUTION IN MAMMALIAN EYES AND EYES OF DIABETICS.
    HADDAD HM.
    Am J Ophthalmol; 1964 Dec 15; 58():979-82. PubMed ID: 14233722
    [No Abstract] [Full Text] [Related]

  • 20. Chemical identification of a tumor-derived angiogenic factor.
    Kull FC, Brent DA, Parikh I, Cuatrecasas P.
    Science; 1987 May 15; 236(4803):843-5. PubMed ID: 2437656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.